文献速递心外重症与机械循环支持

国际心肺移植学会机械辅助循环支持登记中机械循环支持装置接受者的血流感染:流行病学、危险因素与死亡率

Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality.
PubMed 文献 · J Heart Lung Transplant · 2018-04-25

基于国际心肺移植学会机械辅助循环支持(IMACS)登记2013年1月至2015年12月的数据,分析10,171例机械循环支持(MCS)接受者中血流感染(BSI)的发生率、独立危险因素及与死亡率的关系。结果显示12%患者发生BSI,早期BSI与24个月死亡率显著增加独立相关(HR 2.56)。超过85%的BSI与装置无关。

要点

  • MCS接受者中12%发生BSI,早期事件率2.43例/100患者月,晚期1.03例/100患者月。
  • 早期BSI是植入后3个月死亡的独立相关因素(HR 2.56,95%CI 2.09-3.15,p<0.001)。
  • 超过85%的BSI与装置无关,为感染预防实践提供机会。

核心结论

  • 早期BSI与24个月死亡率显著增加相关。
  • 超过85%的BSI与装置无关。
  • 感染预防实践有机会降低BSI事件率,可能影响24个月生存。
  • 这些数据可作为各机构的基准。

研究设计与样本

  • 多中心国际登记研究,使用IMACS登记数据。
  • 纳入2013年1月至2015年12月登记的10,171例MCS接受者。
  • 评估MCS相关和非MCS相关BSI事件率,并进行单变量和多变量分析。

主要发现

  • 10,171例MCS接受者中1,231例(12%)发生1,606次BSI。
  • 植入后3个月内(早期)BSI事件率为2.43次/100患者月,3个月后(晚期)为1.03次/100患者月。
  • 1,378次(85.8%)BSI为非MCS相关。
  • 体质指数增加和胆红素升高是MCS相关BSI的独立相关因素。
  • 非MCS相关BSI的独立相关因素包括年龄较大、体质指数较高、既往心脏手术、基线慢性肾病和透析、植入前衰弱、双心室辅助装置、全人工心脏或右心室辅助装置、INTERMACS 1类。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为感染预防实践有机会降低BSI事件率,可能影响24个月生存。
  • 作者认为这些数据可作为各机构的基准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We used multicenter international data from the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support (IMACS) registry to determine bloodstream infection (BSI) event rate, independent risk factors, and association with mortality. METHODS: Included were patients registered in IMACS from January 2013 through December 2015, assessed BSI event rate of mechanical circulatory support (MCS) and non-MCS-related BSIs, and conducted univariate and multivariate analyses between BSI with baseline characteristics and mortality. RESULTS: We documented 1,606 BSIs in 1,231 of 10,171 MCS recipients (12%), with an event rate of 2.43 BSIs/100 patient-months within 3 months after implant (early onset) and 1.03 BSIs/100 patient-months after 3 months (late onset). Of these episodes, 1,378 (85.8%) were non- MCS-related BSI. Increasing body mass index and bilirubin were independent correlates of MCS-related BSI. Independent correlates of non-MCS-related BSI included older age, higher body mass index, previous cardiac surgery, baseline chronic renal disease and dialysis, pre-implant frailty, presence of biventricular assist device, total artificial heart or right ventricular assist device, and Interagency Registry for Mechanically Assisted Circulatory Support category 1. Survival after 3 months after implant of patients who developed early-onset BSI was 56.9% at 24 months vs 77.4% in patients without early-onset BSI (p < 0.001). Early-onset BSI was an independent correlate of mortality at 3 months after implantation (hazard ratio, 2.56; 95% confidence interval, 2.09-3.15; p < 0.001). CONCLUSIONS: Early-onset BSI was associated with significantly increased 24-month mortality. More than 85% of these BSIs were not device related. There is an opportunity for infection prevention practices to decrease the BSI event rate, which may affect 24-month survival. These data can also serve as benchmarking for individual institutions.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Aslam S, Xie R, Cowger J, et al. Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality. J Heart Lung Transplant. 2018. PMID: 29936085. doi:10.1016/j.healun.2018.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。